BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34689177)

  • 1. HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
    Mikulska M; Penack O; Wendel L; Knelange N; Cornelissen JJ; Blijlevens N; Passweg J; Kroger N; Bruns A; Koenecke C; Bierings M; Piñana JL; Labussiere-Wallet H; Ghesquieres H; Diaz MA; Sampol A; Averbuch D; de la Camara R; Styczynski J
    Bone Marrow Transplant; 2022 Feb; 57(2):167-175. PubMed ID: 34689177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with hepatitis E virus in kidney transplant recipients in southeastern France.
    Moal V; Legris T; Burtey S; Morange S; Purgus R; Dussol B; Garcia S; Motte A; Gérolami R; Berland Y; Colson P
    J Med Virol; 2013 Mar; 85(3):462-71. PubMed ID: 23239466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
    Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
    Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis E after solid organ transplantation.
    de Niet A; Zaaijer HL; ten Berge I; Weegink CJ; Reesink HW; Beuers U
    Neth J Med; 2012 Aug; 70(6):261-6. PubMed ID: 22859417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
    Ambrocio GPL; Aguado S; Carrillo J; Laporta R; Lazaro-Carrasco M; Avellon A; Aran-Toha G; Ussetti M; Aguilar M
    Transplant Proc; 2019 Mar; 51(2):376-379. PubMed ID: 30879545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
    Carter M; Solsrud K; Yeddula S; Fitzmaurice MG; Singh A; Nagai S; Jafri SM
    Transplant Proc; 2022 Sep; 54(7):1737-1741. PubMed ID: 35907694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and treatment of hepatitis E in the liver transplantation setting: A literature review.
    Markakis GE; Papatheodoridis GV; Cholongitas E
    J Viral Hepat; 2022 Sep; 29(9):698-718. PubMed ID: 35644040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis E virus infection in hematopoietic stem cell transplant recipients.
    van der Eijk AA; Pas SD; Cornelissen JJ; de Man RA
    Curr Opin Infect Dis; 2014 Aug; 27(4):309-15. PubMed ID: 24977683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients.
    Swartling L; Nordén R; Samuelsson E; Boriskina K; Valentini D; Westin J; Norder H; Sparrelid E; Ljungman P
    Bone Marrow Transplant; 2020 Jul; 55(7):1255-1263. PubMed ID: 32071417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
    Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
    Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and management strategies for chronic hepatitis E infection.
    Abravanel F; Lhomme S; Marion O; Péron JM; Kamar N; Izopet J
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):143-148. PubMed ID: 36625025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.
    Owada Y; Oshiro Y; Inagaki Y; Harada H; Fujiyama N; Kawagishi N; Yagisawa T; Usui J; Akutsu N; Itabashi Y; Saito K; Watarai Y; Ichimaru N; Imamura R; Kyakuno M; Ide K; Shibuya Y; Okabe Y; Ono M; Sasaki K; Shiose A; Yamagishi K; Ohnishi H; Nagashima S; Takahashi M; Yuzawa K; Okamoto H; Ohkohchi N
    Transplantation; 2020 Feb; 104(2):437-444. PubMed ID: 31205267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study.
    Franz A; Reuken PA; Guliyeva S; Rose M; Boden K; Stallmach A; Bruns T
    J Int Med Res; 2023 Jul; 51(7):3000605231187941. PubMed ID: 37523153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis E in liver transplant recipients in Greece.
    Sinakos Ε; Gioula G; Liava C; Papa A; Papadopoulou E; Tsakni E; Fouzas I; Akriviadis E
    Epidemiol Infect; 2018 Oct; 146(13):1619-1621. PubMed ID: 29974836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.